Recent IMMX Stock Price | IMMX Stock Predictions | |
$2.31 | +506.06% |
$14.00 |
Recent IMMX Analyst Ratings Breakdown, Making IMMX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the IMMX stock predictions from the analysts covering Immix Biopharma Inc, we have collected all of the individual IMMX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering IMMX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since IMMX stock predictions may vary widely, another useful metric to consider is the median IMMX stock prediction, which represents the price at which half of the analysts
made IMMX stock predictions that were higher and half made IMMX stock predictions that were lower. This makes for a different take on the IMMX stock predictions out there, as compared to average or mean.
And that median across all the individual IMMX stock predictions was: $14.0 as of 2024-05-03.
The very highest of the IMMX stock predictions for one year price target was $14.0, while the very lowest of the IMMX stock predictions in the analyst group was
$14.0 (with a standard deviation of $0.0). Get the latest Zacks research report on IMMX — FREE
Find out: IMMX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
OUT Stock Predictions
RHI Stock Predictions
D Stock Predictions
MGEE Stock Predictions
REVG Stock Predictions
ZI Stock Predictions
ROIC Stock Predictions
FCN Stock Predictions
IRTC Stock Predictions
|
|
Strong Buy (4.00 out of 4) 90th percentile
(ranked higher than approx. 90% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |